Novartis subsidiary Sandoz has made available a citrate-free, high-concentration formulation (HCF) of Hyrimoz (adalimumab-adaz) injection, a biosimilar of Humira (adalimumab), in the United States (US).
03 Jul 2023
06 Jun 2023
Rani Therapeutics has expanded its collaboration with Celltrion for developing RT-105, an orally administered adalimumab biosimilar.
22 Nov 2022
Graybug Vision and CalciMedica have signed a definitive merger agreement to create a new clinical-stage biopharmaceutical company.
19 Jan 2022
Galapagos has obtained marketing authorization from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Jyseleca (filgotinib 200mg tablets) to treat ulcerative colitis (UC) in Great Britain.
27 Jan 2021
The US Department of Defense (DOD) has approved the funding of US-based private pharmaceutical firm Humanetics to test its drug candidate BIO 300 in treating pulmonary inflammation triggered by COVID-19.